Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)

Xuanzhu Biopharmaceutical Statistics

Total Valuation

HKG:2575 has a market cap or net worth of HKD 11.88 billion. The enterprise value is 11.16 billion.

Market Cap	11.88B
Enterprise Value	11.16B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2575 has 517.95 million shares outstanding. The number of shares has increased by 3.15% in one year.

Current Share Class	160.70M
Shares Outstanding	517.95M
Shares Change (YoY)	+3.15%
Shares Change (QoQ)	+6.30%
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	5.93%
Float	74.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	206.24
PB Ratio	7.79
P/TBV Ratio	10.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-40.84
EV / Sales	193.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-47.62

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.00.

Current Ratio	3.75
Quick Ratio	3.04
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-1,882.36

Financial Efficiency

Return on equity (ROE) is -21.10% and return on invested capital (ROIC) is -12.53%.

Return on Equity (ROE)	-21.10%
Return on Assets (ROA)	-10.28%
Return on Invested Capital (ROIC)	-12.53%
Return on Capital Employed (ROCE)	-16.45%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	292,449
Profits Per Employee	-1.39M
Employee Count	197
Asset Turnover	0.04
Inventory Turnover	0.36

Taxes

In the past 12 months, HKG:2575 has paid 6,677 in taxes.

Income Tax	6,677
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	37.05
200-Day Moving Average	n/a
Relative Strength Index (RSI)	33.32
Average Volume (20 Days)	2,505,278

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2575 had revenue of HKD 57.61 million and -273.20 million in losses. Loss per share was -0.59.

Revenue	57.61M
Gross Profit	28.62M
Operating Income	-259.74M
Pretax Income	-273.20M
Net Income	-273.20M
EBITDA	-228.83M
EBIT	-259.74M
Loss Per Share	-0.59

Balance Sheet

The company has 725.85 million in cash and 719,988 in debt, with a net cash position of 725.13 million or 1.40 per share.

Cash & Cash Equivalents	725.85M
Total Debt	719,988
Net Cash	725.13M
Net Cash Per Share	1.40
Equity (Book Value)	1.52B
Book Value Per Share	2.94
Working Capital	679.51M

Cash Flow

In the last 12 months, operating cash flow was -233.65 million and capital expenditures -638,753, giving a free cash flow of -234.29 million.

Operating Cash Flow	-233.65M
Capital Expenditures	-638,753
Depreciation & Amortization	32.00M
Net Borrowing	-1.02M
Free Cash Flow	-234.29M
FCF Per Share	-0.45

Margins

Gross Margin	49.67%
Operating Margin	-450.85%
Pretax Margin	-474.20%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2575 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.15%
Shareholder Yield	-3.15%
Earnings Yield	-2.30%
FCF Yield	-1.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2575 has an Altman Z-Score of 64.33 and a Piotroski F-Score of 3.

Altman Z-Score	64.33
Piotroski F-Score	3